Enhancing Health Technology Assessment Establishment in Asia: Practical Issues From the Pharmaceutical and Medical Device Industry Perspectives

Affiliations

• ¹ Global Health Economics, Amgen Asia Holding Limited, Hong Kong, China; Global Health Economics, James L. Winkle College of Pharmacy, University of Cincinnati, Ohio City, OH, USA.
• ² Center for Observational and Real-world Evidence, Merck & Co, Inc, Rahway, NJ, USA. Electronic address: Liu.larry@merck.com.
• ³ Medical Affairs, BeiGene, Ltd, Emeryville, CA, USA.
• ⁴ Health Economics and Real-World Evidence, Elysia Group, LLC, New York, NY, USA.
• ⁵ Health Economics, Pfizer Investment Co Ltd, Beijing, China.
• ⁶ CRECON Medical Assessment Inc, Tokyo, Japan.
• ⁷ Social Security Empirical Research, National Institute of Population and Social Security Research, Tokyo, Japan.
• ⁸ Market Access, Medtronic Korea Ltd, Seoul, South Korea; Market Access, Graduate School for Medical Device Management and Research, Samsung Advanced Institute for Health Science & Technology), Sung Kyun Kwan University, Seoul, Korea.
• ⁹ Global Medical Affairs, Sanofi, Cambridge, MA, USA.